Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC012562 | Panoply™ Human PSENEN Knockdown Stable Cell Line | Inquiry |
| CSC-SC012562 | Panoply™ Human PSENEN Over-expressing Stable Cell Line | Inquiry |
| CSC-RT2047 | PSENEN Knockout Cell Line-HeLa | Inquiry |
| CLKO-1908 | PSENEN KO Cell Lysate-HeLa | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD13042Z | Human PSENEN adenoviral particles | Inquiry |
| LV22889L | human PSENEN (NM_172341) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHR146104 | shRNA set against Human PSENEN(NM_172341.1) | Inquiry |
| SHW017503 | shRNA set against Danio rerio PSENEN (NM_205576) | Inquiry |
| SHH384884 | shRNA set against Human PSENEN (NM_172341.1) | Inquiry |
| SHH384888 | shRNA set against Mouse PSENEN (NM_025498.2) | Inquiry |
| SHH384892 | shRNA set against Rat PSENEN (NM_001008764.2) | Inquiry |
| SHR146108 | shRNA set against Mouse Psenen(NM_025498.2) | Inquiry |
| SHR146256 | shRNA set against Rat Psenen(NM_001008764.2) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCR321587 | Human PSENEN ORF Clone(NM_172341.1) | Inquiry |
| CDCR368962 | Rat Psenen ORF Clone(NM_001008764.2) | Inquiry |
| CDFG010493 | Human PSENEN cDNA Clone(NM_172341.1) | Inquiry |
| CDFG010495 | Human PSENEN cDNA Clone(NM_172341.1) | Inquiry |
| CDFR001931 | Rat Psenen cDNA Clone(NM_001008764.2) | Inquiry |
| MiUTR1H-08363 | PSENEN miRNA 3'UTR clone | Inquiry |
| MiUTR1M-09673 | PSENEN miRNA 3'UTR clone | Inquiry |
| MiUTR1R-06131 | PSENEN miRNA 3'UTR clone | Inquiry |
| CDCB178978 | Danio rerio PSENEN ORF Clone (NM_205576) | Inquiry |
| CDCB189341 | Rabbit PSENEN ORF clone (XM_002722223.2) | Inquiry |
| CDCH068836 | Mouse Psenen ORF clone (NM_025498.2) | Inquiry |
| CDCS417370 | Human PSENEN ORF Clone (BC009575) | Inquiry |
The PEN2 gene, officially named PSENEN, is located on human chromosome 19q13.12. It encodes PEN-2, one of the four essential core subunits of the γ-secretase complex. γ-Secretase is a large multi-pass transmembrane protein complex composed of the catalytic subunit presenilin, the scaffold protein APH-1, the auxiliary protein Nicastrin, and PEN-2. PEN-2 is a small, two-pass transmembrane protein that, despite its modest size, is indispensable for the maturation, stability, and enzymatic activity of the complex. Although not part of the catalytic core, PEN-2 is required for assembling fully active γ-secretase. Studies have shown that PEN-2 regulates the ER retention of presenilin, its autocatalytic maturation, and the correct intracellular localization and accumulation of the active complex.
The biological significance of PEN-2 is inseparable from the function of the γ-secretase complex. γ-Secretase mediates intramembrane proteolysis, cleaving transmembrane proteins within their membrane-spanning regions. This unique activity is central to numerous cellular processes, particularly signal transduction and protein processing. Its most well-known substrates are the amyloid precursor protein (APP) and Notch receptors. Sequential cleavage of APP by γ-secretase generates β-amyloid peptides, especially the aggregation-prone Aβ42, which constitutes the major component of senile plaques in Alzheimer's disease. For Notch receptors, γ-secretase cleavage releases the Notch intracellular domain, which translocates to the nucleus as a transcriptional co-activator to regulate genes controlling cell fate, proliferation, and differentiation. Thus, through its essential role in γ-secretase activity, PEN-2 profoundly influences neural homeostasis and broader developmental processes. Beyond APP and Notch, γ-secretase also processes numerous other substrates, including cadherins and CD44, implicating PEN-2 and the complex in regulating cell adhesion, migration, neurogenesis, and immune responses.
Figure 1. The location of all reported mutations within the c-secretase complex in HS. (Pink AE, et al., 2012)
The clinical significance of PEN2 is linked to γ-secretase's role in two major disease areas: Alzheimer's disease (AD) and Notch pathway–related disorders. In AD, γ-secretase catalyzes the final step in Aβ peptide production and has long been considered a primary target for disease-modifying therapies. However, global γ-secretase inhibitors have repeatedly failed in clinical trials due to strong inhibition of Notch signaling, resulting in severe gastrointestinal and immune toxicities. These challenges have shifted research toward strategies that modulate γ-secretase activity rather than completely inhibit it, or that selectively inhibit APP cleavage while sparing Notch processing. Understanding auxiliary subunits like PEN-2 has become crucial, as they may offer potential targets for fine-tuning complex activity.
Moreover, PEN2 genetic variants have direct disease associations. Loss-of-function mutations in PEN2 cause familial acne inversa (hidradenitis suppurativa, ACNINV2), a chronic inflammatory skin disorder characterized by recurrent abscesses, sinus tracts, and scarring. This condition unexpectedly links γ-secretase function to the development and homeostasis of skin appendages, likely through Notch signaling in hair follicles and sebaceous glands. These findings highlight the physiological importance of PEN-2 in specific tissues and suggest that targeted modulation of local γ-secretase–PEN2 activity could hold therapeutic potential for skin disorders.
References